Synapse - Sergio Giralt

Results (1065)

TP53 mutations in AML predict adverse outcome in patients undergoing allogeneic hematopoietic stem cell transplant

Meeting Abstract

Getta, B. M.; Ghosh, A.; Coombs, C. C.; Devlin, S.; Arcila, M.; Mohanty, A.; Levine, R. L.; Tallman, M. S.; Jakubowski, A. A.; Giralt, S. A.; more...
Blood (2016)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplant with ablative conditioning is associated with favorable outcomes in patients with mixed phenotype acute leukemia

Meeting Abstract

Getta, B. M.; Zheng, J. T.; Tallman, M. S.; Park, J. H.; Stein, E. M.; Roshal, M.; Papadopoulos, E. B.; Kernan, N. A.; Steinherz, P. G.; O'Reilly, R. J.; more...
Blood (2016)

Fulltext@MSK | Save

Immunophenotypic evidence for reactive polyclonal marrow plasmacytosis in multiple myeloma patients receiving long-term lenalidomide therapy

Meeting Abstract

Hassoun, H.; Roshal, M.; Sabari, J.; Cooper, B.; Nguyen, J.; Ruiz, R.; Gao, Q.; Landau, H.; Lendvai, N.; Chung, D. J.; more...
Blood (2016)

Fulltext@MSK | Save

Comparison of standard assays (serum immunofixation and protein electrophoresis) with Hevylite assay in patients with multiple myeloma

Meeting Abstract

Hassoun, H.; Ruiz, R.; Kazunori, M.; Azzi, K.; Devlin, S.; Cooper, B.; Lendvai, N.; Landau, H.; Lesokhin, A. M.; Chung, D. J.; more...
Blood (2016)

Fulltext@MSK | Save

Allogeneic hematopoietic stem cell transplantation is underutilized in patients with myelodysplastic syndromes

Meeting Abstract

Getta, B.; Kishtagari, A.; Hilden, P.; Devlin, S.; Maloy, M. A.; Gonzales, P. K.; Shaffer, B. C.; Ponce, D. M.; Gyurkocza, B.; Barker, J. N.; more...
Blood (2016)

Fulltext@MSK | Save

The Disease Risk Index predicts outcomes including relapse and survival in CD34-selected allogeneic HCT for acute leukemia and myelodysplastic syndrome

Meeting Abstract

Cho, C.; Hilden, P.; Peled, J. U.; Avecilla, S. T.; Barba, P.; Barker, J. N.; Castro-Malaspina, H. R.; Giralt, S. A.; Jakubowski, A. A.; Koehne, G.; more...
Blood (2016)

Fulltext@MSK | Save

Carfilzomib plus high dose melphalan conditioning prior to autologous hematopoietic cell transplantation followed by carfilzomib maintenance in patients with relapsed multiple myeloma

Meeting Abstract

Costa, L. J.; Landau, H.; Chhabra, S.; Hari, P.; Salzman, D.; Saad, A.; Innis-Shelton, R.; Hamadani, M.; Tamari, R.; Godby, K. N.; more...
Blood (2016)

Fulltext@MSK | Save

Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation